Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq ...

Anbio Biotechnology, a global medical technology company focused on in vitro diagnostics, has successfully closed its initial public offering of 1,600,000 Class A ordinary shares at a price of $5. ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

EDT Anbio Biotechnology (NNNN) trading halted, volatility trading pauseOptimize Your Investment Research with SparkEffectively assess a ...

EDT Anbio Biotechnology (NNNN) trading resumesOptimize Your Investment Research with SparkEffectively assess a stock's risks and ...

Anbio Biotechnology Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement ...

Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology ...